Oil States International: A Company That Can't Decide Which Way To Die

# Oil States International: A Company That Can't Decide Which Way To Die

Let's talk about Oil States International (OIS), the small-cap oilfield-services name that has become a perfect little case study in why "record backlog" and "the stock is in freefall" are not contradictions.

Right now OIS trades around $8, on a market cap near $480 million. It spent much of its recent cycle spiking toward $14.50 before coming back down to Earth with a thud, and over the last month alone it's lost nearly 7% of its value. It sits below both its 20-day and 200-day moving averages, and its momentum gauge (RSI) is hovering at 36, quietly approaching oversold. On the daily chart, it just poked its head below the $8.00 round number — the line it had been holding — which means $8 has flipped from a floor to a ceiling. That's not a setup that makes buyers feel warm.

But here is the thing that keeps me up at night about this particular name: the fundamentals and the tape are having a fight, and the tape is winning.

The Bull Case Is Real. That's The Problem.

Read the Q2 2026 report (released July 30) and it is genuinely good. Revenue came in near $157 million, up 8% quarter-over-quarter, and adjusted EPS of $0.14 beat Wall Street's expectations by roughly 27%. The backlog just hit $451 million — a decade high — on a book-to-bill ratio of 1.2x. Management retired the last of its convertible notes, and the company now sits with roughly $18 million of debt against $20 million in cash. Net cash. At a small cap, that balance sheet is a genuine floor, not window dressing.

And the strategy shift is real: over 70% of first-half revenue now comes from offshore and international work, up from about half in 2023. Management is loudly touting a deepwater upcycle for 2027 through 2030, and with crude running near $90 on Strait of Hormuz tension, the demand backdrop for its customers is arguably better than it's been in years.

So why is the stock, which should be celebrating, quietly bleeding?

Because "Future" Is Not A Quarter

Here's the rub that bears have pounced on, and honestly, they're not wrong.

Q3 guidance calls for $157 to $167 million in revenue and $18 to $20 million in adjusted EBITDA. That isn't just flat — it implies a sequential decline from Q2 on both metrics. Full-year revenue guidance was left untouched at $640 to $660 million despite the record backlog. Management wasn't feeling generous with the near-term outlook, and the market respects that caution by discounting the stock.

Then there's the backlog itself — the thing bulls treat as gold. Nearly half of it, 48%, is tied up in multi-year military contracts. Those convert far more slowly, dragging the 12-month backlog conversion rate down to roughly 55% versus the historical 65% to 70% range. A backlog you can't bill fast is a backlog you're financing, not a backlog you're profiting from.

And the financing bit hurts: Q2 saw about $6 million used in operating activities, on the back of a roughly $27 million working-capital and inventory build in the first half. Record backlog, negative operating cash flow, and margins squeezed by elevated tungsten, explosive powder, and copper costs. You can build a beautiful future on a balance sheet that's currently on fire.

My Read

This is a hold, and I'd be careful adding to it here.

The tape is telling me the downtrend is intact and $8 no longer protects anyone. My instinct? Don't chase a falling knife just because the balance sheet is clean. If I wanted exposure, I'd wait for one of two things: a reclaim of the $8.40 to $8.50 zone — a retest of the support that just broke, which would signal buyers have stepped back in — or a fade toward $7.00 to $7.25, where the risk/reward for accumulation actually improves given the net-cash floor. A decisive close below $7.00, by contrast, opens the door toward the $6.27 level.

And there's a binary event on the calendar: next earnings, around October 29. That's the thing that decides whether this is a cyclical-recovery story or a "backlog was never going to save this quarter" story. Until then, the stock is caught in a tug-of-war between a genuinely strong balance sheet and a weak earnings trajectory — and right now, the weak side is pulling harder.

So: respect the tape, respect the net cash, and let the chart and the October earnings tell you which one wins. Not both will.